Kurabe Satoshi, Kumagai Takashi, Abe Hiroshi
Department of Neurosurgery, Tachikawa General Hospital, Nagaoka, Niigata, Japan.
Department of Neurosurgery, Brain Research Institute, University of Niigata, Niigata, Niigata, Japan.
J Neuroendovasc Ther. 2021;15(1):1-7. doi: 10.5797/jnet.ra.2020-0085. Epub 2020 Sep 8.
To evaluate published papers concerning dural arteriovenous fistula involving the superior sagittal sinus (SSS dAVF) treated with endovascular intervention.
A literature review was performed to identify studies reporting the clinical characteristics, vascular anatomy, endovascular techniques, embolic materials, angiographical result, and outcomes of SSS dAVF.
The analysis consisted of 40 case reports or series, comprising a total of 51 cases of SSS dAVF treated with endovascular intervention. Clinical symptoms included hemorrhage (29.4%), infarction (17.6%), and seizure (7.8%). The arterial supply included the middle meningeal artery (MMA) (100%), superficial temporal artery (STA) (62.7%), and occipital artery (OA) (49.0%). Bilateral MMAs supplied in 78.4% of the cases. A pial arterial supply was observed in 21.6% of the cases. Stenosis or occlusion of the sinus was seen in 37.3% of the cases. The distribution of the Borden classification was as follows: I (7.8%), II (37.3%), and III (54.9%). The endovascular techniques were transvenous embolization (TVE) alone (11.8%), transarterial embolization (TAE) alone (74.5%), and a combination thereof (13.7%). The types of embolic materials for TAE were a coil (25.5%), n-butyl-2-cyanoacrylate (NBCA) (33.3%), and Onyx (45.1%). The arterial pedicles for TAE included MMA (86.3%), STA (17.6%), and OA (9.8%). Direct surgical exposure for the alternative endovascular access was performed to the SSS (5.9%), MMA (3.9%), STA (5.9%), and OA (3.9%). Sinus angioplasty with or without stenting was done in 9.8% of the cases. Balloon-assisted Onyx TAE was done with proximal flow control (7.8%), collateral devascularization (5.9%), and sinus protection (3.9%). Complete occlusion was achieved in 86.3% of the cases while the number of endovascular sessions varied among patients: single (74.5%), double (15.7%), and triple (9.8%). The rate of a postoperative modified Rankin Scale (mRS) score of 0-2 was 89.3%, with morbidity and mortality rates of 7.8% and 3.9%, respectively. Two patients died, possibly due to postoperative acute SSS occlusion.
The current systematic review disclosed several specific results, namely, the angioarchitectures of the SSS dAVF, the relationship between classification and hemorrhagic presentation, the diversity of treatment techniques, the association between the complete occlusion rate and the SSS condition, and the difficulty of achieving curable occlusion in a single session. These findings underscore the need for the development of endovascular techniques and devices to treat this challenging lesion. Improvements in adjunctive endovascular procedures, such as balloon-assisted techniques for Onyx TAE, may help support to the safe and effective obliteration of SSS dAVF.
评估已发表的关于采用血管内介入治疗累及上矢状窦的硬脑膜动静脉瘘(SSS dAVF)的论文。
进行文献综述,以确定报告SSS dAVF临床特征、血管解剖、血管内技术、栓塞材料、血管造影结果及预后的研究。
分析包括40篇病例报告或系列研究,共纳入51例接受血管内介入治疗的SSS dAVF患者。临床症状包括出血(29.4%)、梗死(17.6%)和癫痫发作(7.8%)。动脉供血包括脑膜中动脉(MMA)(100%)、颞浅动脉(STA)(62.7%)和枕动脉(OA)(49.0%)。78.4%的病例为双侧MMA供血。21.6%的病例观察到软膜动脉供血。37.3%的病例可见窦狭窄或闭塞。Borden分级分布如下:I级(7.8%)、II级(37.3%)和III级(54.9%)。血管内技术包括单纯经静脉栓塞(TVE)(11.8%)、单纯经动脉栓塞(TAE)(74.5%)及其联合应用(13.7%)。TAE的栓塞材料类型包括弹簧圈(25.5%)、n-丁基-2-氰基丙烯酸酯(NBCA)(33.3%)和Onyx(45.1%)。TAE的动脉蒂包括MMA(86.3%)、STA(17.6%)和OA(9.8%)。对SSS(5.9%)、MMA(3.9%)、STA(5.9%)和OA(3.9%)进行直接手术暴露以作为替代血管内入路。9.8%的病例进行了有或无支架置入的窦血管成形术。采用近端血流控制(7.8%)、侧支血管去血管化(5.9%)和窦保护(3.9%)的球囊辅助Onyx TAE。86.3%的病例实现了完全闭塞,而血管内治疗次数因患者而异:单次(74.5%)、两次(15.7%)和三次(9.8%)。术后改良Rankin量表(mRS)评分为0 - 2分的比例为89.3%,发病率和死亡率分别为7.8%和3.9%。两名患者死亡,可能是由于术后急性SSS闭塞。
当前的系统评价揭示了几个具体结果,即SSS dAVF的血管构筑、分级与出血表现之间的关系、治疗技术的多样性、完全闭塞率与SSS情况之间的关联以及单次实现可治愈闭塞的难度。这些发现强调了开发血管内技术和器械以治疗这种具有挑战性病变的必要性。辅助血管内操作的改进,如球囊辅助Onyx TAE技术,可能有助于支持安全有效地闭塞SSS dAVF。